OSS-1/contamination monitor

A 20-cm high, 18-cm wide, and 30-cm long (8x7x12 inch) box weighing about 7 kg (15 lbs) and consuming about 7 watts of power was carried on the OSS-1 pallet to monitor the mass build-up or accretion of condensible, volatile materials on surfaces in the shuttle bay during all phases of ascent, on-orbit, and descent. Passively thermally controlled, the box holds two witness samples and four actively temperature controlled quartz crystal microbalances (TQCM) whose temperature can vary from -60 C to +80 C. Graphs show the accretion indicated by the TQCM during the launch and early orbital phase. Conditions during tail to the Sun, nose to the Sun, and bay to the Sun attitudes of the shuttle during STS-3 are reflected in temperatures indicated by the OSS-1 thermistor. These temperatures influence outgassing rates of various materials as well as measurements made by the contamination monitor package. The parameters that bear on TQCM measurements data are shown in graphs and discussed

An invariant analytic orthonormalization procedure with applications

We apply the orthonormalization procedure previously introduced by two of us and adopted in connection with coherent states to Gabor frames and other examples. For instance, for Gabor frames we show how to construct $g(x)\in L^2(\Bbb{R})$ in such a way the functions $g_{\underline n}(x)=e^{ian_1x}g(x+an_2)$, $\underline n\in\Bbb{Z}^2$ and $a$ some positive real number, are mutually orthogonal. We discuss in some details the role of the lattice naturally associated to the procedure in this analysis

Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy

Background: Fibrosis may be considered the hallmark of systemic sclerosis (SSc), the end stage triggered by different pathological events. Transforming growth factor-β (TGF-β) and platelet-derived growth factor BB (PDGF-BB) are profibrotic molecules modulating myofibroblast differentiation and proliferation, respectively. There is evidence linking CD248 with these two molecules, both highly expressed in patients with SSc, and suggesting that CD248 may be a therapeutic target for several diseases. The aim of this work was to evaluate the expression of CD248 in SSc skin and its ability to modulate SSc fibrotic process. Methods: After ethical approval was obtained, skin biopsies were collected from 20 patients with SSc and 10 healthy control subjects (HC). CD248 expression was investigated in the skin, as well as in bone marrow mesenchymal stem cells (MSCs) treated with TGF-β or PDGF-BB, by immunofluorescence, qRT-PCR, and Western blotting. Finally, in SSc-MSCs, the CD248 gene was silenced by siRNA. Results: Increased expression of CD248 was found in endothelial cells and perivascular stromal cells of SSc skin. In SSc-MSCs, the levels of CD248 and α-smooth muscle actin expression were significantly higher than in HC-MSCs. In both SSc- and HC-MSCs, PDGF-BB induced increased expression of Ki-67 when compared with untreated cells but was unable to modulate CD248 levels. After CD248 silencing, both TGF-β and PDGF-BB signaling were inhibited in SSc-MSCs. Conclusions: CD248 overexpression may play an important role in the fibrotic process by modulating the molecular target, leading to perivascular cells differentiation toward myofibroblasts and interfering with its expression, and thus might open a new therapeutic strategy to inhibit myofibroblast generation during SSc

Applied neutron tomography in modern archaeology

The use of neutron tomography for archaeometric purposes is quite a new technique. The property of neutron to transmit easily large, dense samples is of great importance in modern archaeology. The three-dimensional visualisation of the inner structure of samples of archaeological interest helps to make suggestions about the technological process of manufacturing or reveals information about the origins of delivering of noble materials used in ancient masterpieces. Another application field in modern archaeology is the non-destructive inspection of the quality of specimen conservation where the neutron tomography allows visualization of impregnation solutions in wood or metal matrices. The high sensibility of neutrons to hydrogen makes it possible to detect organic remains in fossils. All of these advantages make the neutron tomography a unique technique for non-destructive investigation in archaeological sciences

Adsorption on mixtures of ion exchangers

A theoretical study has been made of adsorption on mixtures of ion exchangers. The effect of variables such as the concentration of the ion being adsorbed, the concentration of the supporting electrolyte, loading, the values of the capacities and equilibrium constants for the various exchange processes, and the fraction of each adsorber in the mixture on the observed distribution coefficient has been investigated. A computer program has been written to facilitate the calculation of distribution coefficients for the adsorption of an ion on a given mixture of ion exchangers under a specified set of conditions

A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease

OBJECTIVES: Behçet's disease has been historically classified as a Th1 disease. The recently described IL-17/IL-23 pathway seems to play an important role in many inflammatory diseases and in the intestinal abnormalities of AS and CD. The aim of the present study was to evaluate the IL-17/IL-23 axis in parallel with Th1 and IL-27 response in the intestine of patients with BD and gastrointestinal abnormalities. METHODS: Quantitative TaqMan reverse transcriptase-polymerase chain reaction (RT-PCR) was utilised for all determinations on ileal biopsy specimens obtained from BD, AS and CD patients. The serum levels of Th1 and Th17 cytokines were evaluated by enzyme-linked immunosorbent assay. RESULTS: A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease. CONCLUSIONS: Although BD shares clinical manifestations with both CD and AS, the immunologic abnormalities seen in the intestine are quite different, indicating that other immune mechanisms should be taken into account

A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis

The signs and symptoms of ankylosing spondylitis (AS) respond inadequately to nonsteroidal antiinflammatory drugs, corticosteroids, and disease modifying antirheumatic drugs in quite a number of patients. Tumor necrosis factor inhibitors have demonstrated to be of value in reducing AS disease activity in clinical trials. The efficacy and safety of both etanercept and infliximab in patients with ankylosing spondylitis were compared in a 2-year open label randomised study. Our results are consistent with a significant more rapid clinical improvement in the infliximab treated group. Treatment with both etanercept and infliximab at the end of the study was effective, safe, and well tolerated. \ua9 2009 Springer-Verlag